KNSA
NASDAQ · Biotechnology
Kiniksa Pharmaceuticals Inte
$76.06
-0.45 (-0.59%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+71.50%
1Y
+129.72%
YTD
+81.07%
Open$77.66
Previous Close$76.51
Day High$77.82
Day Low$75.52
52W High$82.94
52W Low$29.66
Volume—
Avg Volume903.0K
Market Cap5.83B
P/E Ratio72.28
EPS$0.98
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$42.51
Above
SMA 200
$35.71
Above
RSI (14)
68.7
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-4.4% upside
Current
$76.06
$76.06
Target
$72.69
$72.69
$47.11
$72.69 avg
$100.82
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 672.83M | 462.59M | 434.64M |
| Net Income | 58.59M | 36.26M | -80,259,876 |
| Profit Margin | 8.7% | 8.3% | -18.5% |
| EBITDA | 78.22M | 51.09M | -90,838,119 |
| Free Cash Flow | — | — | -118,111,706 |
| Rev Growth | +45.5% | +45.5% | +6.7% |
| Debt/Equity | — | — | 0.75 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $246.04 | +0.89% | 122.9 | 446.67B |
| AMGN | Amgen Inc | $410.95 | +1.51% | 26.5 | 206.48B |
| GILD | Gilead Sciences Inc | $133.21 | +1.80% | 17.6 | 161.72B |
| VRTX | Vertex Pharmaceuticals Inc | $496.07 | +2.49% | 27.8 | 120.52B |
| REGN | Regeneron Pharmaceuticals | $782.10 | +1.29% | 17.5 | 77.36B |
| ALNY | Alnylam Pharmaceuticals Inc | $217.68 | +0.72% | 47.7 | 27.52B |